Constitutive activation of STAT3 and STAT5 is present in the majority of nasopharyngeal carcinoma and correlates with better prognosis

被引:0
|
作者
J-R Hsiao
Y-T Jin
S-T Tsai
A-L Shiau
C-L Wu
W-C Su
机构
[1] Institute of Clinical Medicine,Department of Otolaryngology
[2] College of Medicine,Department of Pathology
[3] National Cheng Kung University,Department of Microbiology and Immunology
[4] National Cheng Kung University Hospital,Department of Biochemistry
[5] National Cheng Kung University Hospital,Department of Internal Medicine
[6] College of Medicine,undefined
[7] National Cheng Kung University,undefined
[8] College of Medicine,undefined
[9] National Cheng Kung University,undefined
[10] National Cheng Kung University Hospital,undefined
来源
British Journal of Cancer | 2003年 / 89卷
关键词
signal transducers and activators of transcription (STAT); nasopharyngeal carcinoma (NPC); Epstein–Barr virus (EBV);
D O I
暂无
中图分类号
学科分类号
摘要
Constitutively activated signal transducers and activators of transcription (STAT) factors, in particular STAT1, STAT3 and STAT5, have been demonstrated in a variety of human tumours and cancer cell lines. However, data on the expression of these STATs in nasopharyngeal carcinoma (NPC) are limited. In this study, the expression patterns of STAT1, STAT3 and STAT5 were immunohistochemically examined on the archival specimens from 61 patients with NPC. Staining results of each STATs were then correlated with the clinical parameters and prognosis of these patients. The results showed that constitutive activation of STAT3 and STAT5 was detected in the majority, 70.5 and 62.3%, respectively, of the 61 tumour specimens. Furthermore, coexpression of activated STAT3 and STAT5 was found in 54.1% of the specimens. In contrast, constitutive activated STAT1 could only be detected in 8 (13.1%) cases. Surprisingly, following radiotherapy, patients with constitutive STAT5 activation, or activation of both STAT3 and STAT5, had better disease-free survival and overall survival than those without activated STAT5. To our knowledge, this is the first report providing the overall expression patterns and prognostic significance of specific STATs in NPC.
引用
收藏
页码:344 / 349
页数:5
相关论文
共 50 条
  • [41] Constitutive Activation of Stat1 and Stat3 in Primary Erythroleukemia Cells
    Keita Kirito
    Toshihiro Nagashima
    Keiya Ozawa
    Norio Komatsu
    International Journal of Hematology, 2002, 75 : 51 - 54
  • [42] Constitutive activation of STAT3 and STAT5 is induced by leukemic fusion proteins with protein tyrosine kinase activity and is sufficient for transformation of hematopoietic precursor cells
    Spiekermann, K
    Pau, M
    Schwab, R
    Schmieja, K
    Franzrahe, S
    Hiddemann, W
    EXPERIMENTAL HEMATOLOGY, 2002, 30 (03) : 262 - 271
  • [43] CONSTITUTIVE ACTIVATION OF STAT3 IN RHEUMATOID ARTHRITIS CORRELATES WITH IL-6 LEVELS
    Isomaki, P.
    Junttila, I.
    Vidqvist, K. -L.
    Korpela, M.
    Silvennoinen, O.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 370 - 370
  • [44] The activity of JAK-STAT pathways in rheumatoid arthritis: constitutive activation of STAT3 correlates with interleukin 6 levels
    Isomaki, Pia
    Junttila, Ilkka
    Vidqvist, Krista-Liisa
    Korpela, Markku
    Silvennoinen, Olli
    RHEUMATOLOGY, 2015, 54 (06) : 1103 - 1113
  • [46] Stat5 constitutive activation rescues defects in spinal muscular atrophy
    Ting, Chen-Hung
    Lin, Chiao-Wei
    Wen, Shin-Lan
    Hsieh-Li, Hsiu-Mei
    Li, Hung
    HUMAN MOLECULAR GENETICS, 2007, 16 (05) : 499 - 514
  • [47] Structural Implications of STAT3 and STAT5 SH2 Domain Mutations
    de Araujo, Elvin D.
    Orlova, Anna
    Neubauer, Heidi A.
    Bajusz, David
    Seo, Hyuk-Soo
    Dhe-Paganon, Sirano
    Keseru, Gyorgy M.
    Moriggl, Richard
    Gunning, Patrick T.
    CANCERS, 2019, 11 (11)
  • [48] Expression of STAT3 and STAT5 in non-small cell lung cancers
    Patel, RA
    Owor, G
    Sheehan, CE
    Ross, JS
    Jennings, TA
    MODERN PATHOLOGY, 2005, 18 : 316A - 316A
  • [49] Constitutive activation of STAT1 and STAT3 proteins on serine and tyrosine residues were found in majority of CLL patients.
    Chumchalova, Jitka
    Klimesova, Dana
    Kuhrova, Viera
    Francova, Hana
    Brychtova, Yvona
    Doubek, Michael
    Dvorakova, Dana
    Mayer, Jiri
    BLOOD, 2006, 108 (11) : 319B - 319B
  • [50] Distinct roles of STAT3 and STAT5 in the pathogenesis and targeted therapy of breast cancer
    Walker, Sarah R.
    Xiang, Michael
    Frank, David A.
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2014, 382 (01) : 616 - 621